Granite State Times

In the second quarter of 2024, two Biologics companies received two FDA inspections in New Hampshire, according to the U.S. Food and Drug Administration (FDA).

Biologics companies FDA inspections were the only type of inspections made in New Hampshire during the second quarter of 2024.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

Project Area	No Action Indicated	Voluntary Action Indicated	Official Action Indicated
Blood and Blood Products	2	--	--